1-(3-氯-4-氟苄)哌嗪基色酮衍生物、制备方法及其作为酪氨酸酶抑制剂的应用
By preparing 1-(3-chloro-4-fluorobenzyl)piperazinylchromone derivatives, the problems of insufficient safety, stability and activity of existing tyrosinase inhibitors were solved, and a highly efficient and safe tyrosinase inhibition effect was achieved.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- LANZHOU UNIV SECOND HOSPITAL
- Filing Date
- 2025-12-25
- Publication Date
- 2026-07-17
AI Technical Summary
Existing tyrosinase inhibitors have safety and toxicity issues, insufficient stability, and limited activity, making it difficult to meet the demand for highly effective treatment.
We developed 1-(3-chloro-4-fluorobenzyl)piperazinylchromone derivatives and prepared compounds W1, W2, W3~W14 through specific synthetic steps. These compounds, as tyrosinase inhibitors, exhibit reversible mixed-type inhibitory activity.
1-(3-chloro-4-fluorobenzyl)piperazinylchromone derivatives exhibit highly efficient tyrosinase inhibition with significantly increased IC50 values, and show no cytotoxicity to B16F10 cells in vitro, demonstrating excellent drug-like properties.
Smart Images

Figure CN121758408B_ABST
Abstract
Citation Information
Patent Citations
Chromone dimer capable of inhibiting generation of melanin as well as preparation method and application of chromone dimer
CN117285499A
Use of chromone derivatives
WO2006128562A1